Virbac (VRBCF) has bolstered its specialty pet health portfolio by acquiring a world-leading feline hyperthyroidism treatment from Norbrook, valued at approximately £100 million. The development gives ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2025-12-17 11:37:16















